Senior Care Pharmacy Coalition (SCPC) Announces New Board Chairman, Executive Leadership Team and Board Members￼
WASHINGTON, July 26, 2022 — Brian Kramer, R.Ph., MBA, President of Forum Extended Care Pharmacy based in Chicago, Ill. will serve as the new Chairman of the Senior Care Pharmacy Coalition (SCPC), the Washington D.C.-based advocacy organization announced today. SCPC is the national organization representing long-term care pharmacy interests in Washington, D.C. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country.
Alongside Mr. Kramer, serving on the new SCPC Executive Committee beginning January 1, 2023 for the 2023-2024 term are:
–Chair-Elect Jill Krueger, President and CEO, Symbria, Inc., based in Warrenville, Ill.
–Treasurer Brian Scott, President, HealthDirect,in E. Syracuse, N.Y.
–Secretary Nathan Skaggs, Chief Operating Officer of Pharmacy Unlimited, San Antonio, Texas
–Immediate Past Chair Robert Warnock, R.Ph., Senior Vice President of Pharmacy Services, Pruitt Health, in Norcross, Ga.
Also serving as new Board Members for the 2023-2025 term are:
–Sam Mahfouz, Managing Member, FusionCare Pharmacy, Alexandria, La.
–David Morton, Chief Operating Officer of Neenah, Wis.I-based Morton’s LTC Pharmacy
–Nathan Skaggs, Chief Operating Officer of Pharmacy Unlimited, San Antonio, Texas
–Doug Smock, CEO, Managing Member, Owner of Infinity Pharmacy Solutions and Infinity Pharmacy in Richardson, Texas
–Jason Wachtl, Vice President of Pharmacy and Clinical Programs and Compliance Officer with Geritom Medical in Minneapolis, Minn.
“LTC pharmacies have an essential role in our health care system, serving one of our nation’s most vulnerable populations in skilled nursing facilities, assisted living facilities, the community and other long-term care settings,” said Mr. Kramer. “With 325 members operating in almost every state nationwide, we seek to continue ensuring lawmakers, regulators and other decision makers understand the distinct, essential role of LTC pharmacies in delivering essential patient care services and improving health outcomes. I’d like to thank Robert Warnock for his effective leadership and service on the Board and look forward to continuing to learn and collaborate with him.”
Alan G. Rosenbloom, President & CEO of SCPC, added “SCPC has and continues to play an integral role in ensuring LTC pharmacies and our patients are recognized in legislation given the complex state of health care today. We are driven to improve payments and reduce administrative burdens for LTC pharmacies and enable them to provide high-quality, affordable care safely across the nation.”
About Senior Care Pharmacy Coalition
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies, representing 75% of the sector overall. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.